Trial Profile
Single ascending dose study of TNP-2092 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs TNP 2092 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- 23 Sep 2016 New trial record